» Articles » PMID: 24869958

Advances in Mesenchymal Stem Cell-based Strategies for Cartilage Repair and Regeneration

Overview
Publisher Springer
Specialty Cell Biology
Date 2014 May 30
PMID 24869958
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Significant research efforts have been undertaken in the last decade in the development of stem cell-based therapies for cartilage repair. Among the various stem cell sources, mesenchymal stem cells (MSCs) demonstrate great promise and clinical efficacy in cartilage regeneration. With a deeper understanding of stem cell biology, new therapeutics and new bioengineering approaches have emerged and showed potential for further developments. Of note, there has been a paradigm shift in applying MSCs for tissue regeneration from the use of stem cells for transplantation to the use of stem cell-derived matrix and secretome components as therapeutic tools and agents for cartilage regeneration. In this review, we will discuss the emerging role of MSCs in cartilage regeneration and the most recent advances in development of stem cell-based therapeutics for cartilage regeneration.

Citing Articles

The Potential of Mesenchymal Stem Cell-Derived Exosomes to Treat Diabetes Mellitus.

Kim J, Lee J, Cha G, Yoon J Biomimetics (Basel). 2025; 10(1).

PMID: 39851765 PMC: 11760843. DOI: 10.3390/biomimetics10010049.


The effect of exosomes from canine bone mesenchymal stem cells on IL-1β-mediated inflammatory responses in chondrocytes.

Jiang N, Yang S, Sun Y, Zhang C, Liu K, Huang Y Cytotechnology. 2024; 77(1):27.

PMID: 39736844 PMC: 11682030. DOI: 10.1007/s10616-024-00685-4.


Extracellular vesicles as therapeutic tools in regenerative dentistry.

Xia E, Zou S, Zhao X, Liu W, Zhang Y, Zhao I Stem Cell Res Ther. 2024; 15(1):365.

PMID: 39402576 PMC: 11476107. DOI: 10.1186/s13287-024-03936-5.


Advances in Stem Cell-Based Therapies in the Treatment of Osteoarthritis.

Chen Y, Cheng R, Wu Y, Huang D, Li Y, Liu Y Int J Mol Sci. 2024; 25(1).

PMID: 38203565 PMC: 10779279. DOI: 10.3390/ijms25010394.


Extracellular vesicles in the treatment and prevention of osteoarthritis: can horses help us translate this therapy to humans?.

OBrien T, Hollinshead F, Goodrich L Extracell Vesicles Circ Nucl Acids. 2023; 4(2):151-169.

PMID: 37829144 PMC: 10568983. DOI: 10.20517/evcna.2023.11.


References
1.
Diao H, Yeung C, Yan C, Chan G, Chan B . Bidirectional and mutually beneficial interactions between human mesenchymal stem cells and osteoarthritic chondrocytes in micromass co-cultures. Regen Med. 2013; 8(3):257-69. DOI: 10.2217/rme.13.22. View

2.
Pei M, He F, Boyce B, Kish V . Repair of full-thickness femoral condyle cartilage defects using allogeneic synovial cell-engineered tissue constructs. Osteoarthritis Cartilage. 2009; 17(6):714-22. DOI: 10.1016/j.joca.2008.11.017. View

3.
Li J, Pei M . Optimization of an in vitro three-dimensional microenvironment to reprogram synovium-derived stem cells for cartilage tissue engineering. Tissue Eng Part A. 2010; 17(5-6):703-12. DOI: 10.1089/ten.TEA.2010.0339. View

4.
Zhang W, Chen J, Tao J, Jiang Y, Hu C, Huang L . The use of type 1 collagen scaffold containing stromal cell-derived factor-1 to create a matrix environment conducive to partial-thickness cartilage defects repair. Biomaterials. 2012; 34(3):713-23. DOI: 10.1016/j.biomaterials.2012.10.027. View

5.
Petrie Aronin C, Tuan R . Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells. Birth Defects Res C Embryo Today. 2010; 90(1):67-74. DOI: 10.1002/bdrc.20174. View